当前位置：首页 SCI 期刊医学 Clinica Chimica Acta(非官网)

Clinica Chimica ActaSCIE

国际简称：CLIN CHIM ACTA 参考译名：Acta 化学诊所

中科院分区
3区
CiteScore分区
Q1
JCR分区
Q2

基本信息：: ISSN：0009-8981; E-ISSN：1873-3492; 是否OA：未开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：NETHERLANDS; 出版商：Elsevier; 出版语言：English; 出版周期：Monthly; 出版年份：1956; 研究方向：医学-医学实验技术

评价信息：: 影响因子：3.2; H-index：127; CiteScore指数：10.1; SJR指数：1.016; SNIP指数：1.086

发文数据：: Gold OA文章占比：16.95%; 研究类文章占比：91.13%; 年发文量：327; 自引率：0.02; 开源占比：0.0813; 出版撤稿占比：0; 出版国人文章占比：0.19; OA被引用占比：0.0316...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Clinica Chimica Acta期刊介绍

The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)

Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.

The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.

期刊简介Clinica Chimica Acta期刊介绍

《Clinica Chimica Acta》自1956出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：约3.0个月约5.2周
医学
MEDICAL LABORATORY TECHNOLOGY
SCIE
中科院3区
非预警

Cite Score数据（2024年最新版）Clinica Chimica Acta Cite Score数据

CiteScore：10.1
SJR：1.016
SNIP：1.086

学科类别	分区	排名	百分位
大类：Medicine 小类：Biochemistry (medical)	Q1	10 / 72	86%
大类：Medicine 小类：Biochemistry	Q1	60 / 438	86%
大类：Medicine 小类：Clinical Biochemistry	Q1	18 / 117	85%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Clinica Chimica Acta 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	3区	MEDICAL LABORATORY TECHNOLOGY 医学实验技术	3区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Clinica Chimica Acta JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：MEDICAL LABORATORY TECHNOLOGY	SCIE	Q2	9 / 30	71.7%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：MEDICAL LABORATORY TECHNOLOGY	SCIE	Q1	7 / 30	78.33%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
CHINA MAINLAND660
Spain570
USA256
Italy215
GERMANY (FED REP GER)116
Belgium112
Japan104
France101
England87
India78

本刊中国学者近年发表论文

1、A rapid multiplex assay of human malaria parasites by digital PCR
Author: Dong, Liu; Li, Weijia; Xu, Qianqian; Gu, Jianfei; Kang, Zhihua; Chen, Jian; Xu, Xiao; Zhang, Xinju; Zhang, Xiuming; Jiang, Haoqin; Guan, Ming

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 70-78. DOI: 10.1016/j.cca.2022.12.001
2、The value of lipid metabolites 9,10-DOA and 11,12-EET in prenatal diagnosis of fetal heart defects
Author: Fang, Yiwei; Zhang, Zheng; Zhao, Yun; Sun, Guoqiang; Peng, Meilin; Liu, Chunyan; Yi, Guilin; Zhao, Kai; Yang, Hui

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 544, Issue , pp. -. DOI: 10.1016/j.cca.2023.117330
3、Biomarkers for chemotherapy and drug resistance in the mismatch repair pathway
Author: Dong, Liu; Jiang, Haoqin; Kang, Zhihua; Guan, Ming

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 544, Issue , pp. -. DOI: 10.1016/j.cca.2023.117338
4、Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy
Author: Huang, Ziyue; Wang, Zhensheng; Xia, Haoming; Ge, Ziqiang; Yu, Liang; Li, Jiehan; Bao, Haolin; Liang, Zixin; Cui, Yunfu; Xu, Yi

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 162-169. DOI: 10.1016/j.cca.2022.12.010
5、Diagnostic potential of site-specific serotransferrin N-glycosylation in discriminating different liver diseases
Author: Zhang, Jiyun; Lai, Zhizhen; Ding, Rui; Zhou, Jinyu; Yuan, Zhonghao; Li, Dan; Qin, Xuzhen; Zhou, Jiang; li, Zhili

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 175-183. DOI: 10.1016/j.cca.2022.12.015
6、Fibrinogen beta chain may be a potential predict biomarker for pre-eclampsia: A preliminary study
Author: Shi, Junzhu; Zeng, Shanshui; Zhang, Yonggang; Zuo, Zhihua; Tan, Xiaoyu

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 206-214. DOI: 10.1016/j.cca.2022.12.012
7、Evaluating the value of anti-SARS-CoV-2 antibody detection and neutralizing responses with euvirus: A population of 10776 close contacts in the epidemic of Fujian
Author: Zeng, Yongbin; Lin, Caorui; Liu, Can; Huang, Chun; Chen, Falin; Cao, Yingping; Wu, Siying; Wei, Donghong; Lin, Zhong; Zhang, Yali; Zhang, Ling; Teng, Jing; Li, Zishun; Hong, Guolin; Yang, Tianci; Ye, Huiming; Tu, Haijian; Xiao, Yupeng; Huang, Lishan; Zhang, Jiawei; Chen, Tianbin; Li, Jinming; Ji, Fusui; Ou, Qishui

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 237-243. DOI: 10.1016/j.cca.2022.12.017
8、Intrafollicular fluid metabolic abnormalities in relation to ovarian hyperstimulation syndrome: Follicular fluid metabolomics via gas chromatography-mass spectrometry
Author: Sun, Yixuan; Hao, Lijuan; Han, Wei; Luo, Jing; Zheng, Jing; Yuan, Dong; Ye, Hong; Li, Qinke; Huang, Guoning; Han, Tingli; Yang, Zhu

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 538, Issue , pp. 189-202. DOI: 10.1016/j.cca.2022.11.033